Healius (ASX:HLS) completes acquisition of Agilex Biolabs

Latest Company News - Finance News Network

English - February 01, 2022 01:15 - 1000 KB
Business News News Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Boral (ASX:BLD) unveils plan to return $3b to shareholders

Next Episode: Humm (ASX:HUM) continues talks with Latitude on potential sale

01 Feb 2022 - Healius (ASX:HLS) has completed the acquisition of all of the issued capital of bioanalytical firm Agilex Biolabs, which is valued at $301.3 million.